These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


343 related items for PubMed ID: 15862947

  • 1. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
    St-Laurent V, Sanchez M, Charbonneau C, Tremblay A.
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):23-37. PubMed ID: 15862947
    [Abstract] [Full Text] [Related]

  • 2. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D.
    Cancer Res; 2006 Apr 01; 66(7):3903-11. PubMed ID: 16585219
    [Abstract] [Full Text] [Related]

  • 3. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
    Hua KT, Way TD, Lin JK.
    Mol Carcinog; 2006 Aug 01; 45(8):551-60. PubMed ID: 16637063
    [Abstract] [Full Text] [Related]

  • 4. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation.
    Geraldes P, Sirois MG, Tanguay JF.
    Circ Res; 2003 Sep 05; 93(5):399-405. PubMed ID: 12893737
    [Abstract] [Full Text] [Related]

  • 5. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
    Liu B, Ordonez-Ercan D, Fan Z, Huang X, Edgerton SM, Yang X, Thor AD.
    Mol Cancer Res; 2009 Nov 05; 7(11):1882-92. PubMed ID: 19861407
    [Abstract] [Full Text] [Related]

  • 6. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B.
    J Endocrinol; 2005 Jun 05; 185(3):577-92. PubMed ID: 15930183
    [Abstract] [Full Text] [Related]

  • 7. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
    Sauvé K, Lepage J, Sanchez M, Heveker N, Tremblay A.
    Cancer Res; 2009 Jul 15; 69(14):5793-800. PubMed ID: 19584281
    [Abstract] [Full Text] [Related]

  • 8. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM, Breen K, Rødland MS, Haslekås C, Stang E, Madshus IH.
    Mol Cancer Res; 2009 Feb 15; 7(2):275-84. PubMed ID: 19208749
    [Abstract] [Full Text] [Related]

  • 9. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
    Ariazi EA, Clark GM, Mertz JE.
    Cancer Res; 2002 Nov 15; 62(22):6510-8. PubMed ID: 12438245
    [Abstract] [Full Text] [Related]

  • 10. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K.
    Cancer Res; 2007 Apr 15; 67(8):3955-62. PubMed ID: 17440111
    [Abstract] [Full Text] [Related]

  • 11. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH.
    Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1221-6. PubMed ID: 16169518
    [Abstract] [Full Text] [Related]

  • 12. The Asn418-linked N-glycan of ErbB3 plays a crucial role in preventing spontaneous heterodimerization and tumor promotion.
    Yokoe S, Takahashi M, Asahi M, Lee SH, Li W, Osumi D, Miyoshi E, Taniguchi N.
    Cancer Res; 2007 Mar 01; 67(5):1935-42. PubMed ID: 17332320
    [Abstract] [Full Text] [Related]

  • 13. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
    Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP, Kraus MH.
    Oncogene; 1995 May 04; 10(9):1813-21. PubMed ID: 7538656
    [Abstract] [Full Text] [Related]

  • 14. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z, Shi HY, Nawaz Z, Zhang M.
    Cancer Lett; 2004 Jun 08; 209(1):55-65. PubMed ID: 15145521
    [Abstract] [Full Text] [Related]

  • 15. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
    Schaefer G, Fitzpatrick VD, Sliwkowski MX.
    Oncogene; 1997 Sep 18; 15(12):1385-94. PubMed ID: 9333014
    [Abstract] [Full Text] [Related]

  • 16. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
    Ostrander JH, Daniel AR, Lofgren K, Kleer CG, Lange CA.
    Cancer Res; 2007 May 01; 67(9):4199-209. PubMed ID: 17483331
    [Abstract] [Full Text] [Related]

  • 17. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug 01; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

  • 18. Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells.
    Smith LH, Coats SR, Qin H, Petrie MS, Covington JW, Su M, Eren M, Vaughan DE.
    Circ Res; 2004 Aug 06; 95(3):269-75. PubMed ID: 15217907
    [Abstract] [Full Text] [Related]

  • 19. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
    Contessa JN, Abell A, Mikkelsen RB, Valerie K, Schmidt-Ullrich RK.
    Breast Cancer Res Treat; 2006 Jan 06; 95(1):17-27. PubMed ID: 16267617
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
    Ma C, Lin H, Leonard SS, Shi X, Ye J, Luo J.
    Oncogene; 2003 Aug 14; 22(34):5281-90. PubMed ID: 12917629
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.